Wed.Jul 24, 2024

article thumbnail

FDA blasts Indian CDMO Brassica for 'routine' data falsification, poor hygiene and more

Fierce Pharma

From flubbing data to performing aseptic processing with torn and stained gowns, Brassica Pharma’s recent warning letter from the FDA reads like a textbook example of what not to do when the U.S. | From flubbing data to performing aseptic processing with torn and stained gowns, Brassica Pharma’s recent warning letter from the FDA reads like a textbook example of what not to do when the U.S. regulator comes knocking at your facility.

FDA 218
article thumbnail

What is A Good Base Salary in Sales?

David Bagga

Medical Device Sales Academy What is A Good Base Salary in Sales? In the competitive sales world, salaries vary widely depending on industry, experience, and location. Knowing the salary terrain can be essential to those curious to join medical device sales and to assist in making possible career decisions. Selling medical devices can be a […] The post What is A Good Base Salary in Sales?

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BeiGene CEO eyes biologics deals for new US innovation center in New Jersey

Fierce Pharma

HOPEWELL, NEW JERSEY—A new 42-acre campus in New Jersey gives BeiGene CEO John Oyler hope that the company can strike new partnerships in biologics. | A new 42-acre campus in New Jersey gives BeiGene CEO John Oyler hope that the company can strike new partnerships in biologics.

208
208
article thumbnail

Cigna Addresses Health Disparities Through $9M Commitment

MedCity News

Cigna announced the launch of the Cigna Group Health Equity Impact Fund and committed $9 million on Monday. It will focus on health disparities in Houston, Texas, and Hartford, Connecticut. The post Cigna Addresses Health Disparities Through $9M Commitment appeared first on MedCity News.

108
108
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

How do we make 340B work for patients?

Fierce Pharma

Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics. | What do patients need from 340B? Elizabeth Carpenter, Executive Vice President of Policy and Research at PhRMA, shares the current state of the program and explores opportunities for reform.

Patients 130
article thumbnail

Pfizer Hemophilia Gene Therapy Meets Phase 3 Goals, But Its Success Matters More to Sangamo

MedCity News

Pfizer’s hemophilia A gene therapy reduced annualized bleeding rates in a Phase 3 clinical trial, setting the stage for discussions with regulators. However, the market for such one-time treatments is uncertain, as uptake of commercialized hemophilia gene therapies remains slow. The post Pfizer Hemophilia Gene Therapy Meets Phase 3 Goals, But Its Success Matters More to Sangamo appeared first on MedCity News.

Marketing 106

More Trending

article thumbnail

The Right to Privacy — What a Novel Concept

MedCity News

The current piecemeal state-by-state regulation approach is a feeble patchwork and ready for collapse under the first strong blow. It’s high time we craft a robust and uniform effort to safeguard our patients’ digital rights. The post The Right to Privacy — What a Novel Concept appeared first on MedCity News.

Patients 104
article thumbnail

PBMs under the cosh at House hearing on drug pricing

pharmaphorum

The top three pharmacy benefit managers in the US felt the heat at a hearing of the House Oversight Committee, as lawmakers grilled executives over their business practices and accused them of monopolising the supply chain.

article thumbnail

MedCity Pivot Podcast: Eye As the Window to Your Health With Vicky Demas

MedCity News

Vicky Demas, CEO of identifeye Health, talks about the company’s approach to probe the retina with its proprietary device and companion algorithm. The reitna, she believes, holds the clues to overall health. The post MedCity Pivot Podcast: Eye As the Window to Your Health With Vicky Demas appeared first on MedCity News.

article thumbnail

Investing in Small Business Sales Training

Integrity Solutions

In an increasingly complex and competitive business world, small businesses often face unique challenges that can hinder their growth and success. One of the most critical areas where small businesses can gain a competitive edge is by investing in their teams’ development, particularly through sales training. Small business sales training is not just about learning how to sell more products or services; it’s about transforming the mindset of your sales team, enhancing the value they

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Patients Want Personalized Digital Experiences. Could a Modular Back End Help?

MedCity News

To personalize the patient journey, hospitals need a digital back end capable of delivering tailored experiences. Here’s how a composable digital experience platform (DXP) works and how it can help you offer multiple layers of personalization to meet your patient’s needs. The post Patients Want Personalized Digital Experiences. Could a Modular Back End Help?

Patients 101
article thumbnail

Sales Training Strategies: Overcome Challenges and Drive Success

Quantified

Executive Summary Mastering sales training strategies is crucial for overcoming challenges and driving success. Traditional sales kickoffs often fail to engage and prepare teams effectively. Modernizing events with interactive elements like AI role-playing scenarios, live product demos, and gamified training boosts engagement and retention.AI-driven personalized coaching addresses seller blind spots through targeted training and real-time feedback, leading to continuous improvement and higher su

article thumbnail

Study suggests targeting amyloid beta production could be promising in AD

PharmaTimes

The neurodegenerative disease is currently the most common cause of dementia

126
126
article thumbnail

Standing ovation for Gilead as it boasts perfect efficacy in HIV PReP trial

Pharmaceutical Technology

The crowd and panel gave Gilead a standing ovation after the full data from the Phase III PURPOSE trial was announced at AIDS 2024.

98
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

MSD stakes claim to RSV prevention market for infants

pharmaphorum

MSD's phase 2b/3 data with clesrovimab for RSV prevention in infants sets up a challenge to Sanofi and AstraZeneca's fast-growing Beyfortus

article thumbnail

Quality Considerations for Using AI in Bio/Pharma

PharmaTech

In the second episode of the Ask the Expert video series, Susan J. Schneipp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice-president, Technical, at Parexel, discuss the quality requirements needed when incorporating AI in bio/pharmaceutical development and manufacturing.

Pharma 69
article thumbnail

Asarina folds as it ends search for Tourette's drug partner

pharmaphorum

Asarina Pharma has abandoned its partner search for Tourette's drug sepranolone and will go into liquidation.

Pharma 90
article thumbnail

Triastek and BioNTech to develop 3D-printed RNA therapeutics

Pharmaceutical Technology

BioNTech and Triastek have entered a research partnership focusing on the development of 3D-printed oral RNA therapeutics.

72
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Biogen, Sage drug for essential tremor flunks mid-stage test

pharmaphorum

Biogen's $3bn alliance with Sage has had another setback after a drug for essential tremor failed a phase 2 study.

81
article thumbnail

Pharma Pulse 7/24/24: Addressing OUD Treatment Gaps, Body Dysmorphic Disorder Most Common in Adolescent Girls & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Super Soldier or Medical Sales Rep?

Contrarian Sales Techniques

Captain America – saving the world, throwing his shield – pretty epic stuff, right? But hold on, there might be more to Cap than meets the eye. Think about it. Steve Rogers, the guy behind the Captain America suit, is all about fighting for what's right, using his strength and skills to help others. Sound familiar? In medical sales, we might not be super soldiers, but we share that same drive to make a positive impact.

article thumbnail

The Future of Plastic Surgery And Aesthetics With Sam Cooper, Part 2

Evolve Your Success

Unlock the secrets to a thriving career in medical sales as we chat with Sam Cooper from InMode. From understanding the intricate dynamics of sales teams to mastering the art of selling high-value equipment, Sam shares invaluable insights that will guide you to success in the aesthetic industry. Discover the crucial roles played by sales reps, managers, directors, clinical specialists, and marketing teams, and learn how perseverance and strategic career planning can set you apart in this competi

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Q2 Biopharma Recap

Zymewire

As the second quarter of 2024 comes to a close, the biopharma landscape continues to evolve with dynamic shifts in funding, clinical trials, and innovative developments. Zymewire is back to provide you with a comprehensive digest of what's happened in Q2, to help inform smarter business decisions going forward.

article thumbnail

BeiGene enhances biologic capability with new US facility

European Pharmaceutical Review

BeiGene has opened its flagship US manufacturing facility in Hopewell, New Jersey. The 42-acre facility provides flexibility to scale production of novel cancer treatments. The company highlighted that its oncology pipeline addresses “80 percent of the world’s cancers”. “Addition of our facility at the Princeton West Innovation Campus adds manufacturing and clinical development capabilities…to advance quality medicines faster for patients,” commented John Oyler , Co-Founder, Chairman and CEO of

article thumbnail

Red Yeast Rice Supplement Recall in Japan After Potential Link to Deaths

Contrarian Sales Techniques

Yikes! A popular Japanese dietary supplement company, Kobayashi Pharmaceutical , is recalling its red yeast rice tablets after reports that they may be linked to several deaths. These tablets are supposed to help lower cholesterol. Kobayashi is being slammed for how they handled the situation, as they didn't warn consumers right away. An investigation found that the company didn't take the issue seriously enough.

Doctors 52
article thumbnail

Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Pfizer Pumps Up Singapore's Pharma Industry with $1 Billion Plant

Contrarian Sales Techniques

Pfizer is investing a cool $1 billion to build a new plant in Singapore ! This is a big deal for a few reasons. First, it'll create around 250 new jobs , which is always good news. Second, the plant will be making all sorts of medicines we use every day, from cancer treatments to painkillers and antibiotics. And lastly, this investment puts Singapore on the map as a leader in the biomedical sciences industry.

Pharma 52
article thumbnail

Phase III Trial Data Demonstrates Efficacy of Lenacapavir in Preventing HIV in Cisgender Women

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Merck and GTRI to develop gene therapy for Parkinson’s disease

Pharmaceutical Technology

Merck has entered a non-binding MoU with the Gene Therapy Research Institution (GTRI) to produce a gene therapy for Parkinson's disease.

52
article thumbnail

Pharma Pulse 7/24/24: Now is Not the Time to End the Global AIDS Effort, Preparing for the Next Worldwide Tech Outage & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.